HomePBYI • NASDAQ
Puma Biotechnology Inc
add
$3.01
2.73%
After Hours:(0.33%)-0.0100
$3.00
Closed: Apr 2, 4:14:30 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 59.08M | -18.15% |
Operating expense | 31.79M | -1.98% |
Net income | 19.31M | 57.36% |
Net profit margin | 32.68 | 92.24% |
Earnings per share | 0.43 | 38.71% |
EBITDA | 16.21M | -11.50% |
Effective tax rate | -57.75% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 100.97M | 5.24% |
Total assets | 213.33M | -7.46% |
Total liabilities | 121.21M | -31.55% |
Total equity | 92.13M | — |
Shares outstanding | 49.61M | — |
Price to book | 1.56 | — |
Return on assets | 15.40% | — |
Return on capital | 20.65% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 19.31M | 57.36% |
Cash from operations | 15.61M | 49.28% |
Cash from investing | -2.32M | 71.60% |
Cash from financing | -11.33M | — |
Net change in cash | 1.96M | -14.40% |
Free cash flow | 10.21M | -23.87% |
Previous close
$2.93
Day range
$2.88 - $3.03
Year range
$2.23 - $6.06
Market cap
149.33M USD
Avg Volume
460.00K
P/E ratio
4.88
Dividend yield
-
Primary exchange
NASDAQ
About
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
Founded
2007
Headquarters
Website
Employees
172
